Lipka L J, Lathers C M, Roberts J
Department of Pharmacology, Medical College of Pennsylvania, Philadelphia.
J Clin Pharmacol. 1988 Nov;28(11):968-83. doi: 10.1002/j.1552-4604.1988.tb03117.x.
The influence of the central nervous system in the production of phenothiazine-induced arrhythmia and death was examined in this study. In a series of cats, spinal cords were transected at the atlanto-occipital junction prior to the 1 mg/kg/min, i.v. infusion of chlorpromazine or thioridazine. No protection against drug-induced arrhythmia or death was afforded by this procedure. In other cats, 6OH-dopamine was administered prior to intravenous injection of atropine and infusion of chlorpromazine, 1 mg/kg/min. In these in situ denervated heart preparations, there was no protection against chlorpromazine-induced arrhythmia or death. In alpha-chloralose anesthetized cats, 0.5 mg chlorpromazine administered intracerebroventricularly did not induce arrhythmia or death, although blood pressure decreased initially. Thus, chlorpromazine or thioridazine do not appear to produce arrhythmia or death via a central locus and may instead be acting directly on myocardial conduction to produce arrhythmia and death.
本研究考察了中枢神经系统在吩噻嗪诱导的心律失常和死亡过程中的作用。在一系列猫中,于静脉注射氯丙嗪或硫利达嗪(速率为1mg/kg/min)之前,在枕寰关节处横断脊髓。此操作未对药物诱导的心律失常或死亡起到保护作用。在其他猫中,于静脉注射阿托品及输注氯丙嗪(速率为1mg/kg/min)之前给予6-羟基多巴胺。在这些原位去神经心脏标本中,未对氯丙嗪诱导的心律失常或死亡起到保护作用。在α-氯醛糖麻醉的猫中,脑室内给予0.5mg氯丙嗪虽最初使血压下降,但未诱发心律失常或死亡。因此,氯丙嗪或硫利达嗪似乎并非通过中枢位点产生心律失常或死亡,而是可能直接作用于心肌传导从而导致心律失常和死亡。